Growth in the use of microbiome sequencing in early disease diagnosis and utilization of this technology in the development of personalized medicines for various diseases are the driving factors for the microbiome sequencing market.
Growth in the use of microbiome sequencing in early disease diagnosis and utilization of this technology in the development of personalized medicines for various diseases are the driving factors for the microbiome sequencing market.